Human Papillomavirus-Related Gynecologic Neoplasms: Screening and Prevention

Por Growdon, Whitfield B, Del Carmen, Marcela
Publicado em 2008

The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer

Por J. Diver, Elisabeth, Foster, Rosemary, Rueda, Bo R., Growdon, Whitfield B.
Publicado no Oncologist (2015)

Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer

Por Garrett, Leslie A., Growdon, Whitfield B., Rueda, Bo R., Foster, Rosemary
Publicado no J Ovarian Res (2016)

Notch signaling in serous ovarian cancer

Por Groeneweg, Jolijn W, Foster, Rosemary, Growdon, Whitfield B, Verheijen, René HM, Rueda, Bo R
Publicado no J Ovarian Res (2014)

Laparoscopic Surgical Staging of Early Ovarian Cancer

Por Weber, Sarah, McCann, Christopher K, Boruta, David M, Schorge, John O, Growdon, Whitfield B
Publicado em 2011

The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas

Por May, Taymaa, Shoni, Melina, Vitonis, Allison F., Quick, Charles M., Growdon, Whitfield B., Muto, Michael G.
Publicado em 2013

The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells

Por Bellio, Chiara, DiGloria, Celeste, Spriggs, David R., Foster, Rosemary, Growdon, Whitfield B., Rueda, Bo R.
Publicado no Cancers (Basel) (2019)

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

Por Groeneweg, Jolijn W., DiGloria, Celeste M., Yuan, Jing, Richardson, William S., Growdon, Whitfield B., Sathyanarayanan, Sriram, Foster, Rosemary, Rueda, Bo R.
Publicado em 2014

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant

Por Growdon, Whitfield B., Groeneweg, Jolijn, Byron, Virginia, DiGloria, Celeste, Borger, Darrell R., Tambouret, Rosemary, Foster, Rosemary, Chenna, Ahmed, Sperinde, Jeff, Winslow, John, Rueda, Bo R.
Publicado no Gynecol Oncol (2015)

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau

Por Starbuck, Kristen, Al-Alem, Linah, Eavarone, David A., Hernandez, Silvia Fatima, Bellio, Chiara, Prendergast, Jillian M., Stein, Jenna, Dransfield, Daniel T., Zarrella, Bianca, Growdon, Whitfield B., Behrens, Jeff, Foster, Rosemary, Rueda, Bo R.
Publicado no Oncotarget (2018)

Upregulation of MUC4 in Cervical Squamous Cell Carcinoma: Pathologic Significance

Por Munro, Elizabeth G., Jain, Maneesh, Oliva, Esther, Kamal, Neel, Lele, Subodh M., Lynch, Maureen P., Guo, Lankai, Fu, Kai, Sharma, Poonam, Remmenga, Steve, Growdon, Whitfield B., Davis, John S., Rueda, Bo R., Batra, Surinder K.
Publicado em 2009

Dual HER2 Targeting Impedes Growth of HER2 Gene Amplified Uterine Serous Carcinoma Xenografts

Por Groeneweg, Jolijn W., Hernandez, Silvia F., Byron, Virginia F., DiGloria, Celeste M., Lopez, Hector, Scialabba, Vanessa, Kim, Minji, Zhang, Ling, Borger, Darrell R., Tambouret, Rosemary, Foster, Rosemary, Rueda, Bo R., Growdon, Whitfield B.
Publicado no Clin Cancer Res (2014)

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome

Por Engler, David A., Gupta, Sumeet, Growdon, Whitfield B., Drapkin, Ronny I., Nitta, Mai, Sergent, Petra A., Allred, Serena F., Gross, Jenny, Deavers, Michael T., Kuo, Wen-Lin, Karlan, Beth Y., Rueda, Bo R., Orsulic, Sandra, Gershenson, David M., Birrer, Michael J., Gray, Joe W., Mohapatra, Gayatry
Publicado em 2012

Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model

Por McCann, Christopher K., Growdon, Whitfield B., Kulkarni-Datar, Kashmira, Curley, Michael D., Friel, Anne M., Proctor, Jennifer L., Sheikh, Hana, Deyneko, Igor, Ferguson, Jeanne A., Vathipadiekal, Vinod, Birrer, Michael J., Borger, Darrell R., Mohapatra, Gayatry, Zukerberg, Lawrence R., Foster, Rosemary, MacDougall, John R., Rueda, Bo R.
Publicado em 2011

Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer

Por Matsuo, Koji, Cripe, James C., Kurnit, Katherine C., Kaneda, Michiko, Garneau, Audrey S., Glaser, Gretchen E., Nizam, Aaron, Schillinger, Rachel M., Kuznick, Michelle L., Yabuno, Akira, Yanai, Shiori, Garofalo, Denise M., Suzuki, Jiro, St. Laurent, Jessica D., Yen, Ting-Tai, Liu, Annie Y., Shida, Masako, Kakuda, Mamoru, Oishi, Tetsuro, Nishio, Shin, Marcus, Jenna Z., Adachi, Sosuke, Kurokawa, Tetsuji, Ross, Malcolm S., Horowitz, Max P., Johnson, Marian S., Kim, Min K., Melamed, Alexander, Machado, Karime K., Yoshihara, Kosuke, Yoshida, Yoshio, Enomoto, Takayuki, Ushijima, Kimio, Satoh, Shinya, Ueda, Yutaka, Mikami, Mikio, Rimel, Bobbie J., Stone, Rebecca L., Growdon, Whitfield B., Okamoto, Aikou, Guntupalli, Saketh R., Hasegawa, Kosei, K. Shahzad, Mian M., Im, Dwight D., Frimer, Marina, Gostout, Bobbie S., Ueland, Frederick R., Nagao, Shoji, Soliman, Pamela T., Thaker, Premal H., Wright, Jason D., Roman, Lynda D.
Publicado no Gynecol Oncol (2019)